Sunshine Biopharma Inc. Investment Income, Nonoperating
Sunshine Biopharma Inc. (SBFM) reported Investment Income, Nonoperating of $48.82 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeNonoperating · last filed 2026-08-13
- Sunshine Biopharma Inc. investment income, nonoperating for the quarter ending 2026-06-30 was $48.82K, a 32.87% decline year-over-year.
- Sunshine Biopharma Inc. investment income, nonoperating for the quarter ending 2025-06-30 was $72.72K.
| Period end | Investment Income, Nonoperating 3 month | Investment Income, Nonoperating 6 month |
|---|---|---|
| 2026-06-30 | $48.82K 10-Q · filed 2026-08-13 | $97.24K 10-Q · filed 2026-08-13 |
| 2025-06-30 | $72.72K 10-Q · filed 2026-08-13 | $148.08K 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |